Normal lactational environment restores cardiomyocyte number after uteroplacental insufficiency: Implications for the preterm neonate

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 9, 2012, Pages

  Jane Black, M ^a   Siebel, Andrew L ^b,c   Gezmish, Oksan ^a   Moritz, Karen M ^d   Wlodek, Mary E ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Developmental origins of health and disease; Early life growth restriction; heart; Early life programming; Intrauterine growth restriction

Indexed keywords

MESSENGER RNA; MYC PROTEIN; MYOSIN HEAVY CHAIN; PROTEIN BCL 2; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; BREAST DISEASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HEART DEVELOPMENT; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; INFANT NUTRITION; LACTATION; MALE; MAMMARY GLAND; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA INSUFFICIENCY; POSTNATAL GROWTH; PREMATURITY; PRIORITY JOURNAL; PROGENY; RAT;

ANIMALS; ANIMALS, NEWBORN; BREAST FEEDING; CELL COUNT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LACTATION; MALE; MYOCYTES, CARDIAC; PLACENTAL CIRCULATION; PLACENTAL INSUFFICIENCY; PREGNANCY; RATS; RATS, INBRED WKY;

EID: 84860511325     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00030.2012     Document Type: Article

References (51)

1. Barker DJ. Birth weight and hypertension. Hypertension 48: 357-358, 2006.
2. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 298: 564-567, 1989.
3. Battista MC, Oligny LL, St-Louis J, Brochu M. Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood. Am J Physiol Endocrinol Metab 283: E124-E131, 2002.
4. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001.
5. Bensley JG, Stacy VK, De Matteo R, Harding R, Black MJ. Cardiac remodelling as a result of pre-term birth: implications for future cardiovascular disease. Eur Heart J 31: 2058-2066, 2010.
6. Bocconi L, Mauro F, Maddalena SE, De Iulio C, Tirelli AS, Pace E, Nicolini U. Insulinlike growth factor 1 in controls and growth-retarded fetuses. Fetal Diagn Ther 13: 192-196, 1998.
7. Bubb KJ, Cock ML, Black MJ, Dodic M, Boon WM, Parkington HC, Harding R, Tare M. Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep. J Physiol 578: 871-881, 2007.
8. Camm EJ, Hansell JA, Kane AD, Herrera EA, Lewis C, Wong S, Morrell NW, Giussani DA. Partial contributions of developmental hypoxia and undernutrition to prenatal alterations in somatic growth and cardiovascular structure and function. Am J Obstet Gynecol 203: 495 e424-e434, 2010.
9. Catalucci D, Latronico MV, Ellingsen O, Condorelli G. Physiological myocardial hypertrophy: how and why? Front Biosci 13: 312-324, 2008.
10. Chatterjee A, Mir SA, Dutta D, Mitra A, Pathak K, Sarkar S. Analysis of p53 and NF-kappaB signaling in modulating the cardiomyocyte fate during hypertrophy. J Cell Physiol 226: 2543-2554, 2011.
11. Corstius HB, Zimanyi MA, Maka N, Herath T, Thomas W, van der Laarse A, Wreford NG, Black MJ. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res 57: 796-800, 2005.
12. Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, Le Noble F, Ahmed A, Gratacos E. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 121: 2427-2436, 2010.
13. Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE, Speizer FE, Stampfer MJ. Birth weight and adult hypertension and obesity in women. Circulation 94: 1310-1315, 1996.
14. Dos Santos E, Dieudonne MN, Leneveu MC, Serazin V, Rincheval V, Mignotte B, Chouillard E, De Mazancourt P, Giudicelli Y, Pecquery R. Effects of 17β-estradiol on preadipocyte proliferation in human adipose tissue: Involvement of IGF1-R signaling. Horm Metab Res 42: 514-520, 2010.
15. Eriksson J, Forsen T, Tuomilehto J, Osmond C, Barker D. Fetal and childhood growth and hypertension in adult life. Hypertension 36: 790-794, 2000.
16. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. Br Med J 318: 427-431, 1999.
17. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Acta Pathol Microbiol Immunol Scand 96: 857-881, 1988.
18. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA. The post-natal heart contains a myocardial stem cell population. FEBS Lett 530: 239-243, 2002.
19. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95: 8801-8805, 1998.
20. Leon DA, Lithell HO, Vagero D, Koupilova I, Mohsen R, Berglund L, Lithell UB, McKeigue PM. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15,000 Swedish men and women born 1915-1929. Br Med J 317: 241-245, 1998.
21. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746, 1996.
22. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746, 1996.
23. 2+ homeostasis, protein damage and apoptotic protein expression. Aging Cell 6: 799-806, 2007.
24. Lim K, Zimanyi MA, Black MJ. Effect of maternal protein restriction during pregnancy and lactation on the number of cardiomyocytes in the postproliferative weanling rat heart. Anat Rec (Hoboken) 293: 431-437, 2010.
25. Louey S, Jonker SS, Giraud GD, Thornburg KL. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J Physiol 580: 639-648, 2007.
26. Lumbers ER, Kim MY, Burrell JH, Kumarasamy V, Boyce AC, Gibson KJ, Gatford KL, Owens JA. Effects of intrafetal IGF-I on growth of cardiac myocytes in late-gestation fetal sheep. Am J Physiol Endocrinol Metab 296: E513-E519, 2009.
27. Mayhew TM, Gregson C, Fagan DG. Ventricular myocardium in control and growth-retarded human fetuses: growth in different tissue compartments and variation with fetal weight, gestational age, and ventricle size. Hum Pathol 30: 655-660, 1999.
28. Mazzuca MQ, Wlodek ME, Dragomir NM, Parkington HC, Tare M. Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. J Physiol 588: 1997-2010, 2010.
29. Moritz KM, Cuffe JS, Wilson LB, Dickinson H, Wlodek ME, Simmons DG, Denton KM. Sex specific programming: a critical role for the renal renin-angiotensin system. Placenta 31 Suppl: S40-S46, 2010.
30. Moritz KM, Mazzuca MQ, Siebel AL, Mibus A, Arena D, Tare M, Owens JA, Wlodek ME. Uteroplacental insufficiency causes a nephron deficit, modest renal insufficiency but no hypertension with ageing in female rats. J Physiol 587: 2635-2646, 2009.
31. Morrison JL, Botting KJ, Dyer JL, Williams SJ, Thornburg KL, McMillen IC. Restriction of placental function alters heart development in the sheep fetus. Am J Physiol Regul Integr Comp Physiol 293: R306-R313, 2007.
32. O'Dowd R, Kent JC, Moseley JM, Wlodek ME. Effects of uteroplacental insufficiency and reducing litter size on maternal mammary function and postnatal offspring growth. Am J Physiol Regul Integr Comp Physiol 294: R539-R548, 2008.
33. Resnik R. Intrauterine growth restriction. Obstet Gynecol 99: 490-496, 2002.
34. Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett WC, Hennekens CH. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br Med J 315: 396-400, 1997.
35. Robson SC, Ward L, Brown H, Turner H, Hunter E, Pelengaris S, Khan M. Deciphering c-MYC-regulated genes in two distinct tissues. BMC Genomics 12: 476, 2011.
36. Rudolph AM. Myocardial growth before and after birth: clinical implications. Acta Paediatr 89: 129-133, 2000.
37. Rueda-Clausen CF, Morton JS, Davidge ST. Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc Res 81: 713-722, 2009.
38. Siebel AL, Gallo LA, Guan TC, Owens JA, Wlodek ME. Crossfostering and improved lactation ameliorates deficits in endocrine pancreatic morphology in growth-restricted adult male rat offspring. Dev Origins Health Dis 1: 234-244, 2010.
39. Siebel AL, Mibus A, De Blasio MJ, Westcott KT, Morris MJ, Prior L, Owens JA, Wlodek ME. Improved lactational nutrition and postnatal growth ameliorates impairment of glucose tolerance by uteroplacental insufficiency in male rat offspring. Endocrinology 149: 3067-3076, 2008.
40. Stacy V, De Matteo R, Brew N, Sozo F, Probyn ME, Harding R, Black MJ. The influence of naturally occurring differences in birthweight on ventricular cardiomyocyte number in sheep. Anat Rec (Hoboken) 292: 29-37, 2009.
41. Sundgren NC, Giraud GD, Schultz JM, Lasarev MR, Stork PJ, Thornburg KL. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am J Physiol Regul Integr Comp Physiol 285: R1481-R1489, 2003.
42. Sundgren NC, Giraud GD, Stork PJ, Maylie JG, Thornburg KL. Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes. J Physiol 548: 881-891, 2003.
43. Wadley GD, Siebel AL, Cooney GJ, McConell GK, Wlodek ME, Owens JA. Uteroplacental insufficiency and reducing litter size alters skeletal muscle mitochondrial biogenesis in a sex-specific manner in the adult rat. Am J Physiol Endocrinol Metab 294: E861-E869, 2008.
44. Wang KC, Zhang L, McMillen IC, Botting KJ, Duffield JA, Zhang S, Suter CM, Brooks DA, Morrison JL. Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb. J Physiol 589: 4709-4722, 2011.
45. Weber KT, Clark WA, Janicki JS, Shroff SG. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium. J Cardiovasc Pharmacol 10 Suppl 6: S37-S50, 1987.
46. Wlodek ME, Mibus A, Tan A, Siebel AL, Owens JA, Moritz KM. Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol 18: 1688-1696, 2007.
47. Wlodek ME, Westcott K, Siebel AL, Owens JA, Moritz KM. Growth restriction before or after birth reduces nephron number and increases blood pressure in male rats. Kidney Int 74: 187-195, 2008.
48. Wlodek ME, Westcott KT, O'Dowd R, Serruto A, Wassef L, Moritz KM, Moseley JM. Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP. Am J Physiol Regul Integr Comp Physiol 288: R1620-R1627, 2005.
49. Wlodek ME, Westcott KT, Serruto A, O'Dowd R, Wassef L, Ho PW, Moseley JM. Impaired mammary function and parathyroid hormonerelated protein during lactation in growth-restricted spontaneously hypertensive rats. J Endocrinol 178: 233-245, 2003.
50. Xue Q, Dasgupta C, Chen M, Zhang L. Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury. Cardiovasc Res 89: 300-308, 2011.
51. Xue Q, Zhang L. Prenatal hypoxia causes a sex-dependent increase in heart susceptibility to ischemia and reperfusion injury in adult male offspring: role of protein kinase C epsilon. J Pharmacol Exp Ther 330: 624-632, 2009.